BiochemistrybioRxivPreprint
Molecular docking between human TMPRSS2 and the serine protease Kunitz-type inhibitor rBmTI-A
L. d. M. Bomediano-Camillo, S. D. Sasaki
This study investigates the molecular docking of rBmTI-A with TMPRSS2, showing it binds effectively at the SARS-CoV-2 cleavage site with high affinity.
DOI 10.1101/2022.03.13.484191